How CBT Is Used to Treat PTSD
A clinician overview of CBT for PTSD — the core protocols, how exposure and cognitive restructuring work, and how to sequence treatment.
Cognitive behavioral therapy is the most thoroughly researched treatment for post-traumatic stress disorder, and several CBT-based protocols carry strong evidence as first-line interventions. If you treat trauma, understanding how these protocols overlap and differ helps you choose the right fit and stay within your competence.
The evidence-based protocols
Several manualized approaches fall under the CBT umbrella for PTSD:
- Prolonged Exposure (PE): combines imaginal exposure (revisiting the trauma memory) with in vivo exposure to avoided situations.
- Cognitive Processing Therapy (CPT): targets the stuck points — beliefs about safety, trust, power, esteem, and intimacy — that the trauma created or reinforced.
- Trauma-Focused CBT (TF-CBT): a phased model designed for children and adolescents, integrating psychoeducation, coping skills, a trauma narrative, and cognitive restructuring.
- Cognitive Therapy for PTSD (Ehlers & Clark): identifies and updates trauma-related appraisals and triggers.
All share a common engine: helping the client approach, rather than avoid, trauma-relevant material so that the memory and its meanings can update.
How exposure and restructuring work together
Avoidance is the maintaining factor in PTSD. Exposure interrupts avoidance, allowing the fear structure to habituate and the memory to integrate into autobiography. Cognitive restructuring then corrects the meanings the brain assigned under threat — "it was my fault," "nowhere is safe." Done well, the two reinforce each other.
Sequencing and safety
Stabilization comes first. Before trauma-focused work, clients need grounding, affect-regulation skills, and a sense of safety. Rushing into exposure with a dysregulated client can worsen symptoms. Build the coping skills toolbox and practice grounding techniques before moving to the trauma narrative.
Documentation and risk
Trauma treatment carries clinical risk: monitor for dissociation, worsening symptoms, and suicidality throughout. Document risk assessments regularly — a suicide risk assessment template keeps that documentation consistent — and use validated measures like the PCL-5 to track change.